Immunology Market Forecast (2024-2032)

The Immunology Market research provides a comprehensive evaluation of several key factors, including product success, market share growth, and investment opportunities in an emerging market. The latest analysis offers a detailed overview of the Immunology Market, highlighting factors that could impact future growth, potential opportunities, and current trends. It includes an assessment of revenue market size, as well as market drivers, constraints, and opportunities. The study also outlines the competitive landscape, detailing the market share of leading industry players.

This report explores the market structure, segmentation, growth rates, and revenue share comparisons. It delivers a high-level summary of the market and its potential. The research offers an in-depth analysis of the Immunology Market, with projections and estimates derived from extensive secondary research, primary interviews, and expert insights. These forecasts consider the influence of various political, social, and economic factors, along with current market conditions, on market growth.

Market Segmentation
This study explores revenue growth at the country level and current industry trends within each sub-segment. By analyzing market segmentation, you gain a detailed understanding of market dynamics and can monitor its progress. This section delves into the Immunology Market’s segmentation by regions and countries, providing a detailed breakdown of revenues, market shares, and potential growth opportunities.

Key Segments:
By Drug Class

• Monoclonal Antibody (mAb)
• Fusion Proteins
• Immunosuppressants
• Polyclonal Antibody (pAb)

By Disease Indication

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Plaque Psoriasis
• Ankylosing Spondylitis
• Inflammatory Bowel Disease
• Prophylaxis of Organ Rejection

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COVID-19 Impact Analysis

This report examines the effects of COVID-19 on the Immunology Market at a country level. It aims to help market participants develop effective pandemic preparedness strategies by analyzing both demand and supply-side impacts. The study incorporates data from primary and secondary research, private databases, and a paid data source.

Key Market Players: 

• Amgen Inc.
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Johnson and Johnson Inc.
• Novartis AG
• Pfizer Inc. and other.

TABLE OF CONTENTS

1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Industry Flowchart

3. Research Methodology

4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges

5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India

6. Value Chain Analysis

7. Porter’s 5 Forces Model

8.  Pest Analysis

9. Immunology Market, By Drug Class
9.1 Introduction
9.2 Trend Analysis
9.3 Monoclonal Antibody (mAb)
9.4 Fusion Proteins
9.5 Immunosuppressant
9.6 Polyclonal Antibody (pAb)

10. Immunology Market, By Disease Indicator
10.1 Introduction
10.2 Trend Analysis
10.3 Rheumatoid Arthritis
10.4 Psoriatic Arthritis
10.5 Plaque Psoriasis
10.6 Ankylosing Spondylitis
10.7 inflammatory Bowel Disease
10.8 Prophylaxis of Organ Rejection

11. Immunology Market, By Distribution Channel
11.1 Introduction
11.2 Trend Analysis
11.3 Hospital pharmacies
11.4 Retail pharmacies
11.5 Online pharmacies

12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America Immunology Market by Country
12.2.3 North America Immunology Market By Drug class
12.2.4 North America Immunology Market By Disease indicator
12.2.5 North America Immunology Market By Distribution channel
12.2.6 USA
12.2.6.1 USA Immunology Market By Drug class
12.2.6.2 USA Immunology Market By Disease indicator
12.2.6.3 USA Immunology Market By Distribution channel
12.2.7 Canada
12.2.7.1 Canada Immunology Market By Drug class
12.2.7.2 Canada Immunology Market By Disease indicator
12.2.7.3 Canada Immunology Market By Distribution channel
12.2.8 Mexico
12.2.8.1 Mexico Immunology Market By Drug class
12.2.8.2 Mexico Immunology Market By Disease indicator
12.2.8.3 Mexico Immunology Market By Distribution channel
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe Immunology Market by Country
12.3.2.2 Eastern Europe Immunology Market By Drug class
12.3.2.3 Eastern Europe Immunology Market By Disease indicator
12.3.2.4 Eastern Europe Immunology Market By Distribution channel
12.3.2.5 Poland
12.3.2.5.1 Poland Immunology Market By Drug class
12.3.2.5.2 Poland Immunology Market By Disease indicator
12.3.2.5.3 Poland Immunology Market By Distribution channel
12.3.2.6 Romania
12.3.2.6.1 Romania Immunology Market By Drug class
12.3.2.6.2 Romania Immunology Market By Disease indicator
12.3.2.6.4 Romania Immunology Market By Distribution channel
12.3.2.7 Hungary
12.3.2.7.1 Hungary Immunology Market By Drug class
12.3.2.7.2 Hungary Immunology Market By Disease indicator
12.3.2.7.3 Hungary Immunology Market By Distribution channel
12.3.2.8 Turkey
12.3.2.8.1 Turkey Immunology Market By Drug class
12.3.2.8.2 Turkey Immunology Market By Disease indicator
12.3.2.8.3 Turkey Immunology Market By Distribution channel
12.3.2.9 Rest of Eastern Europe
12.3.2.9.1 Rest of Eastern Europe Immunology Market By Drug class
12.3.2.9.2 Rest of Eastern Europe Immunology Market By Disease indicator
12.3.2.9.3 Rest of Eastern Europe Immunology Market By Distribution channel
12.3.3 Western Europe
12.3.3.1 Western Europe Immunology Market by Country
12.3.3.2 Western Europe Immunology Market By Drug class
12.3.3.3 Western Europe Immunology Market By Disease indicator
12.3.3.4 Western Europe Immunology Market By Distribution channel
12.3.3.5 Germany
12.3.3.5.1 Germany Immunology Market By Drug class
12.3.3.5.2 Germany Immunology Market By Disease indicator
12.3.3.5.3 Germany Immunology Market By Distribution channel
12.3.3.6 France
12.3.3.6.1 France Immunology Market By Drug class
12.3.3.6.2 France Immunology Market By Disease indicator
12.3.3.6.3 France Immunology Market By Distribution channel
12.3.3.7 UK
12.3.3.7.1 UK Immunology Market By Drug class
12.3.3.7.2 UK Immunology Market By Disease indicator
12.3.3.7.3 UK Immunology Market By Distribution channel
12.3.3.8 Italy
12.3.3.8.1 Italy Immunology Market By Drug class
12.3.3.8.2 Italy Immunology Market By Disease indicator
12.3.3.8.3 Italy Immunology Market By Distribution channel
12.3.3.9 Spain
12.3.3.9.1 Spain Immunology Market By Drug class
12.3.3.9.2 Spain Immunology Market By Disease indicator
12.3.3.9.3 Spain Immunology Market By Distribution channel
12.3.3.10 Netherlands
12.3.3.10.1 Netherlands Immunology Market By Drug class
12.3.3.10.2 Netherlands Immunology Market By Disease indicator
12.3.3.10.3 Netherlands Immunology Market By Distribution channel
12.3.3.11 Switzerland
12.3.3.11.1 Switzerland Immunology Market By Drug class
12.3.3.11.2 Switzerland Immunology Market By Disease indicator
12.3.3.11.3 Switzerland Immunology Market By Distribution channel
12.3.3.1.12 Austria
12.3.3.12.1 Austria Immunology Market By Drug class
12.3.3.12.2 Austria Immunology Market By Disease indicator
12.3.3.12.3 Austria Immunology Market By Distribution channel
12.3.3.13 Rest of Western Europe
12.3.3.13.1 Rest of Western Europe Immunology Market By Drug class
12.3.3.13.2 Rest of Western Europe Immunology Market By Disease indicator
12.3.3.13.3 Rest of Western Europe Immunology Market By Distribution channel
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific Immunology Market by Country
12.4.3 Asia-Pacific Immunology Market By Drug class
12.4.4 Asia-Pacific Immunology Market By Disease indicator
12.4.5 Asia-Pacific Immunology Market By Distribution channel
12.4.6 China
12.4.6.1 China Immunology Market By Drug class
12.4.6.2 China Immunology Market By Disease indicator
12.4.6.3 China Immunology Market By Distribution channel
12.4.7 India
12.4.7.1 India Immunology Market By Drug class
12.4.7.2 India Immunology Market By Disease indicator
12.4.7.3 India Immunology Market By Distribution channel
12.4.8 Japan
12.4.8.1 Japan Immunology Market By Drug class
12.4.8.2 Japan Immunology Market By Disease indicator
12.4.8.3 Japan Immunology Market By Distribution channel
12.4.9 South Korea
12.4.9.1 South Korea Immunology Market By Drug class
12.4.9.2 South Korea Immunology Market By Disease indicator
12.4.9.3 South Korea Immunology Market By Distribution channel
12.4.10 Vietnam
12.4.10.1 Vietnam Immunology Market By Drug class
12.4.10.2 Vietnam Immunology Market By Disease indicator
12.4.10.3 Vietnam Immunology Market By Distribution channel
12.4.11 Singapore
12.4.11.1 Singapore Immunology Market By Drug class
12.4.11.2 Singapore Immunology Market By Disease indicator
12.4.11.3 Singapore Immunology Market By Distribution channel
12.4.12 Australia
12.4.12.1 Australia Immunology Market By Drug class
12.4.12.2 Australia Immunology Market By Disease indicator
12.4.12.3 Australia Immunology Market By Distribution channel
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Immunology Market By Drug class
12.4.13.2 Rest of Asia-Pacific Immunology Market By Disease indicator
12.4.13.3 Rest of Asia-Pacific Immunology Market By Distribution channel
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East Immunology Market by Country
12.5.2.2 Middle East Immunology Market By Drug class
12.5.2.3 Middle East Immunology Market By Disease indicator
12.5.2.4 Middle East Immunology Market By Distribution channel
12.5.2.5 UAE
12.5.2.5.1 UAE Immunology Market By Drug class
12.5.2.5.2 UAE Immunology Market By Disease indicator
12.5.2.5.3 UAE Immunology Market By Distribution channel
12.5.2.6 Egypt
12.5.2.6.1 Egypt Immunology Market By Drug class
12.5.2.6.2 Egypt Immunology Market By Disease indicator
12.5.2.6.3 Egypt Immunology Market By Distribution channel
12.5.2.7 Saudi Arabia
12.5.2.7.1 Saudi Arabia Immunology Market By Drug class
12.5.2.7.2 Saudi Arabia Immunology Market By Disease indicator
12.5.2.7.3 Saudi Arabia Immunology Market By Distribution channel
12.5.2.8 Qatar
12.5.2.8.1 Qatar Immunology Market By Drug class
12.5.2.8.2 Qatar Immunology Market By Disease indicator
12.5.2.8.3 Qatar Immunology Market By Distribution channel
12.5.2.9 Rest of Middle East
12.5.2.9.1 Rest of Middle East Immunology Market By Drug class
12.5.2.9.2 Rest of Middle East Immunology Market By Disease indicator
12.5.2.9.3 Rest of Middle East Immunology Market By Distribution channel
12.5.3 Africa
12.5.3.1 Africa Immunology Market by Country
12.5.3.2 Africa Immunology Market By Drug class
12.5.3.3 Africa Immunology Market By Disease indicator
12.5.3.4 Africa Immunology Market By Distribution channel
12.5.3.5 Nigeria
12.5.3.5.1 Nigeria Immunology Market By Drug class
12.5.3.5.2 Nigeria Immunology Market By Disease indicator
12.5.3.5.3 Nigeria Immunology Market By Distribution channel
12.5.3.6 South Africa
12.5.3.6.1 South Africa Immunology Market By Drug class
12.5.3.6.2 South Africa Immunology Market By Disease indicator
12.5.3.6.3 South Africa Immunology Market By Distribution channel
12.5.3.7 Rest of Africa
12.5.3.7.1 Rest of Africa Immunology Market By Drug class
12.5.3.7.2 Rest of Africa Immunology Market By Disease indicator
12.5.3.7.3 Rest of Africa Immunology Market By Distribution channel
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America Immunology Market by country
12.6.3 Latin America Immunology Market By Drug class
12.6.4 Latin America Immunology Market By Disease indicator
12.6.5 Latin America Immunology Market By Distribution channel
12.6.6 Brazil
12.6.6.1 Brazil Immunology Market By Drug class
12.6.6.2 Brazil Immunology Market By Disease indicator
12.6.6.3 Brazil Immunology Market By Distribution channel
12.6.7 Argentina
12.6.7.1 Argentina Immunology Market By Drug class
12.6.7.2 Argentina Immunology Market By Disease indicator
12.6.7.3 Argentina Immunology Market By Distribution channel
12.6.8 Colombia
12.6.8.1 Colombia Immunology Market By Drug class
12.6.8.2 Colombia Immunology Market By Disease indicator
12.6.8.3 Colombia Immunology Market By Distribution channel
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Immunology Market By Drug class
12.6.9.2 Rest of Latin America Immunology Market By Disease indicator
12.6.9.3 Rest of Latin America Immunology Market By Distribution channel

13 Company profile
13.1 UCB SA
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Treatment/End-User/Offerings
13.1.4 SWOT Analysis
13.1.5 Publisher View
13.2 AbbVie Inc.
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Treatment/End-User/Offerings
13.2.4 SWOT Analysis
13.2.5 Publisher View
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Treatment/End-User/Offerings
13.3.4 SWOT Analysis
13.3.5 Publisher View
13.4 Astellas
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Treatment/End-User/Offerings
13.4.4 SWOT Analysis
13.4.5 Publisher View
13.5 Pfizer Inc.
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Treatment/End-User/Offerings
13.5.4 SWOT Analysis
13.5.5 Publisher View
13.6 Amgen Inc.
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Treatment/End-User/Offerings
13.6.4 SWOT Analysis
13.6.5 Publisher View
13.7 ALLERGAN
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Treatment/End-User/Offerings
13.7.4 SWOT Analysis
13.7.5 Publisher View
13.8 Novartis AG
13.8.2 Financials
13.8.3 Treatment/End-User/Offerings
13.8.4 SWOT Analysis
13.8.5 Publisher View
13.9 Bristol-Myers Squibb Company
13.9.1 Market Overview
13.9.2 Financials
13.9.3 Treatment/End-User/Offerings
13.9.4 SWOT Analysis
13.9.5 Publisher View
13.10 Janssen Global Services, LLC (Johnson & Johnson)
13.10.1 Market Overview
13.10.2 Financials
13.10.3 Treatment/End-User/Offerings
13.10.4 SWOT Analysis
13.10.5 Publisher View

14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions

15. Use Case and Best Practices

16. Conclusion